{"entity":{"type":"insider","cik":"0001277477","url":"/insider/0001277477","json_url":"/insider/0001277477.json","name":"CHANEY PAUL G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":11,"first":"2004-08-31","last":"2015-02-23","span_basis":"filed_date"},"name_variants":[{"name":"CHANEY PAUL G","source":"filing","n_filings":11,"first_seen":"2004-08-31","last_seen":"2015-02-23"}],"transactions":[{"id":8821922,"accession":"0001144204-15-011511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-011511","line_url":"/filing/0001144204-15-011511#line-1","is_derivative":false,"issuer_cik":"0001277477","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001277477","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8333.0,"shares_display":"8,333","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":49998.0,"total_display":"49,998.00","shares_owned_after":8333.0,"shares_owned_after_display":"8,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-19","filed_date":"2015-02-23","scope":"insider"},{"id":1453191,"accession":"0001293941-05-000070","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001293941-05-000070","line_url":"/filing/0001293941-05-000070#line-6","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79082.0,"shares_display":"79,082","price_per_share":17.89,"price_display":"17.89","price_state":"stated","total_value":1414776.98,"total_display":"1,414,776.98","shares_owned_after":30595.0,"shares_owned_after_display":"30,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-04","filed_date":"2005-11-07","scope":"insider"},{"id":1453190,"accession":"0001293941-05-000070","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001293941-05-000070","line_url":"/filing/0001293941-05-000070#line-5","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15476.0,"shares_display":"15,476","price_per_share":17.89,"price_display":"17.89","price_state":"stated","total_value":276865.64,"total_display":"276,865.64","shares_owned_after":143542.0,"shares_owned_after_display":"143,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-04","filed_date":"2005-11-07","scope":"insider"},{"id":1195699,"accession":"0001293941-05-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001293941-05-000057","line_url":"/filing/0001293941-05-000057#line-2","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":11.33,"price_display":"11.33","price_state":"stated","total_value":31724.0,"total_display":"31,724.00","shares_owned_after":30595.0,"shares_owned_after_display":"30,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-08-01","filed_date":"2005-08-01","scope":"insider"},{"id":1700388,"accession":"0001293941-05-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001293941-05-000055","line_url":"/filing/0001293941-05-000055#line-2","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":12.68,"price_display":"12.68","price_state":"stated","total_value":35504.0,"total_display":"35,504.00","shares_owned_after":30595.0,"shares_owned_after_display":"30,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-01","filed_date":"2005-07-01","scope":"insider"},{"id":1674073,"accession":"0001293941-05-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001293941-05-000038","line_url":"/filing/0001293941-05-000038#line-2","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":12.98,"price_display":"12.98","price_state":"stated","total_value":36344.0,"total_display":"36,344.00","shares_owned_after":595.0,"shares_owned_after_display":"595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-01","filed_date":"2005-06-03","scope":"insider"},{"id":1404042,"accession":"0001293941-05-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001293941-05-000013","line_url":"/filing/0001293941-05-000013#line-2","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":36.45,"price_display":"36.45","price_state":"stated","total_value":145800.0,"total_display":"145,800.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-31","filed_date":"2005-02-02","scope":"insider"},{"id":1260977,"accession":"0001293941-05-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001293941-05-000001","line_url":"/filing/0001293941-05-000001#line-2","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":45.19,"price_display":"45.19","price_state":"stated","total_value":180760.0,"total_display":"180,760.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-12-31","filed_date":"2005-01-04","scope":"insider"},{"id":304142,"accession":"0001304279-04-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001304279-04-000002","line_url":"/filing/0001304279-04-000002#line-2","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":40.3,"price_display":"40.30","price_state":"stated","total_value":161200.0,"total_display":"161,200.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-30","filed_date":"2004-11-30","scope":"insider"},{"id":599171,"accession":"0001277477-04-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001277477-04-000003","line_url":"/filing/0001277477-04-000003#line-2","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-10-29","filed_date":"2004-11-01","scope":"insider"},{"id":528354,"accession":"0001293941-04-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001293941-04-000014","line_url":"/filing/0001293941-04-000014#line-2","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":33.22,"price_display":"33.22","price_state":"stated","total_value":498300.0,"total_display":"498,300.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-09-30","filed_date":"2004-10-01","scope":"insider"},{"id":603568,"accession":"0001277477-04-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001277477-04-000002","line_url":"/filing/0001277477-04-000002#line-2","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277477","owner_name":"CHANEY PAUL G","owner_url":"/insider/0001277477","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":34.96,"price_display":"34.96","price_state":"stated","total_value":524400.0,"total_display":"524,400.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-31","filed_date":"2004-08-31","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001372514","name":"EYEGATE PHARMACEUTICALS INC","url":"/issuer/0001372514","role":"Director","n_filings":1,"first_seen":"2015-02-23","last_seen":"2015-02-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001115285","name":"EYETECH PHARMACEUTICALS INC","url":"/issuer/0001115285","role":"Officer (Chief Operating Officer)","n_filings":10,"first_seen":"2004-08-31","last_seen":"2005-11-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001277477","retrieved_at":"2026-08-21T10:17:55+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}